Skip to main content
. 2019 May 14;39(5):BSR20190027. doi: 10.1042/BSR20190027

Table 1. Clinicopathological parameters of included patient with NPC.

Parameters Number (%)
Age
  <40 20 (45.5%)
  ≥40 24 (54.5%)
Gender
  Male 29 (65.9%)
  Female 15 (34.1%)
TNM stage
  III 21 (47.7%)
  IV 23 (52.3%)
Pathological type
  Differentiated 8 (18.2%)
  Undifferentiated 36 (81.8%)
Prior treatment
  Nasopharynx GTVnx 41.9 ± 25.6
  Lymph GTVnx 23.9 ± 38.4
Lymph reduction rate 0.57 ± 0.29
  >0.50 26 (59.1%)
  ≤0.5 18 (40.9%)
Overall reduction rate (%) 0.57 ± 0.23
  >0.50 27 (61.4%)
  ≤0.5 17 (38.6%)